94 Followers on Owler
OverviewCompetitorsFundingNews & Insights

VIVUS Competitors or Alternatives

VIVUS's top competitors include Arena, Orexigen Therapeutics, Inc. and Array BioPharma.

Unlock 13 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

VIVUS's company profile

John Amos

CEO

88/100
100 - 250
$84.6M
$5M - 25M
  • $84.6M
    $5M - 25M
  • 100 - 250
    $84.6M
  • $5M - 25M
  • 88/100
  • 100 - 250
  • $84.6M
  • $5M - 25M
View ProfileView
1
VIVUS's Competitor - Arena logo

Amit D. Munshi

President & CEO

87/100
250 - 500
$258.6M
$1B - 5B
  • $258.6M
    $1B - 5B
  • 250 - 500
    $258.6M
  • $1B - 5B
  • 87/100
  • 250 - 500
  • $258.6M
  • $1B - 5B
View ProfileView
2
VIVUS's Competitor - Orexigen Therapeutics, Inc. logo

Michael A Narachi

President & CEO

76/100
100 - 250
$269.6M
$25M - 100M
  • $269.6M
    $25M - 100M
  • 100 - 250
    $269.6M
  • $25M - 100M
  • 76/100
  • 100 - 250
  • $269.6M
  • $25M - 100M
View ProfileView
3
VIVUS's Competitor - Array BioPharma logo

CEO

- -
250 - 500
$188.8M
$100M - 500M
  • $188.8M
    $100M - 500M
  • 250 - 500
    $188.8M
  • $100M - 500M
  • - -
  • 250 - 500
  • $188.8M
  • $100M - 500M
View ProfileView
4
VIVUS's Competitor - Gilead logo

Daniel O’Day

Chairman & CEO

66/100
17,000
$7.5B
$28.8B
  • $7.5B
    $28.8B
  • 17,000
    $7.5B
  • $28.8B
  • 66/100
  • 17,000
  • $7.5B
  • $28.8B
View ProfileView
5
VIVUS's Competitor - Bristol-Myers Squibb logo

Christopher Boerner

CEO

44/100
34,300
$23.5B
$48.3B
  • $23.5B
    $48.3B
  • 34,300
    $23.5B
  • $48.3B
  • 44/100
  • 34,300
  • $23.5B
  • $48.3B
View ProfileView
VIVUS's top 16 competitors are Arena, Orexigen Therapeutics, Inc., Array BioPharma, Regeneron, Gilead, Bristol-Myers Squibb, Agios, TESARO, Diffusion Pharmaceuticals, Athersys, Loxo Oncology, Viriom, Relay, Escient, Domain Therapeutics and Obalon. Together they have raised over 37.6B between their estimated 66.3K employees. VIVUS's revenue is the ranked 14th among it's top 10 competitors. The top 10 competitors average 5.5B. VIVUS has 120 employees and is ranked lowest among it's top 10 competitors. The top 10 competitors average 3,909.

VIVUS VS Arena

Arena is VIVUS's #1 rival. Arena is a Private company that was founded in San Diego, California in 1997. Like VIVUS, Arena also works within the Pharmaceuticals field. Arena has 328 more employees vs. VIVUS.

VIVUS VS Array BioPharma

Array BioPharma is a top competitor of VIVUS. Array BioPharma is a Private company that was founded in 1998 in Boulder, Colorado. Like VIVUS, Array BioPharma also operates in the Pharmaceuticals space. Compared to VIVUS, Array BioPharma has 178 more employees.

Looking for similar companies to VIVUS?

Similar Companies

Companies in Campbell with employees in 100-250 range

See 153 companies 
Pharmaceuticals companies in San Francisco Bay Area

See 512 companies 
Companies in Campbell with revenue in $5.0-25M range

See 671 companies 
Pharmaceuticals companies with employees in 100-250 range

See 813 companies 
Pharmaceuticals companies in California

See 1,457 companies 
Pharmaceuticals & Biotechnology companies in San Francisco Bay Area

See 1,673 companies 
Pharmaceuticals & Biotechnology companies with employees in 100-250 range

See 1,792 companies 
Pharmaceuticals companies with revenue in $5.0-25M range

See 2,473 companies 
Pharmaceuticals & Biotechnology companies in California

See 4,181 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for VIVUS and VIVUS's Competitors

March 31, 2025Pharmabiz
Bristol Myers Squibb announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended ap...
April 1, 2025PR Newswire
/PRNewswire/ -- Domain Therapeutics ("Domain" or "the Company"), the GPCR experts harnessing deep receptor biology to develop breakthrough treatments f...
March 31, 2025Finance News Network
31 Mar 2025 - Landmark agreement ensures access for children with Graft versus Host Disease....
March 31, 2025SiliconRepublic
BMS' Karen Costello talks about navigating change and challenges in the rapidly advancing biopharma sector.Read more: A day in the life of a general ma...
March 31, 2025FinanzNachrichten
NEW YORK CITY (dpa-AFX) - Halozyme Therapeutics, Inc. (HALO), Monday announced that Bristol Myers Squibb (BMY) received a positive opinion from the Com...
March 30, 2025GlobeNewswire
United States Centers for Medicare and Medicaid Services (CMS) Mandates Ryoncil® CoverageUnited States Centers for Medicare and Medicaid Services (CMS)...

Frequently Asked Questions about VIVUS

  1. Who are VIVUS's top competitors?

    VIVUS's top 3 competitors are Arena, Orexigen Therapeutics, Inc., Array BioPharma.

  2. Who is similar to VIVUS?

    Arena is the most similar to VIVUS. Orexigen Therapeutics, Inc. and Array BioPharma are also similar to VIVUS.

  1. Are VIVUS and Arena competitors?

    Yes, Arena is one of VIVUS’s top competitors.